Diazepam Pharmacokinetics and Clinical Implications

Pharmacokinetic Properties

Diazepam's high lipid solubility directly results in its large volume of distribution, making it more extensively distributed into tissues compared to less lipophilic benzodiazepines, as noted by the Society of Critical Care Medicine 1, 2
Diazepam is highly lipid soluble, resulting in a quicker onset of sedation and a larger volume of distribution than lorazepam, according to the Society of Critical Care Medicine 1, 2

After single IV administration, diazepam is rapidly redistributed from the central compartment into peripheral tissues, which terminates its clinical effect within 15-20 minutes despite its long half-life, as reported in Pediatrics 3
With repeated dosing, diazepam accumulates in peripheral tissues due to saturation, leading to prolonged clinical effects, although this fact is from Praxis Medical Insights, a similar conclusion may be drawn from other sources, however, this is the only available reference 4

Elderly patients have significantly increased sensitivity to benzodiazepine effects due to both pharmacokinetic and pharmacodynamic changes, as noted by the Society of Critical Care Medicine 1, 2
Active metabolites prolong sedation, particularly in patients with renal failure, according to the Society of Critical Care Medicine 1, 2

The American Academy of Pediatrics recommends a waiting time before neurologic examination after diazepam discontinuation in critically ill pediatric patients, which varies by age, with neonates requiring 50-95 hours 5

In pediatric patients, the waiting time before neurologic examination after diazepam discontinuation is recommended to be 40-50 hours for those aged 1 month to 2 years, and 15-21 hours for those aged 2-12 years, according to the Pediatrics journal 5